Bibliographic Details
| Title: |
Genome-wide association study implicates CHRNA2 in cannabis use disorder. |
| Authors: |
Demontis, Ditte (AUTHOR), Rajagopal, Veera Manikandan (AUTHOR), Thorgeirsson, Thorgeir E. (AUTHOR), Als, Thomas D. (AUTHOR), Grove, Jakob (AUTHOR), Leppälä, Kalle (AUTHOR), Gudbjartsson, Daniel F. (AUTHOR), Pallesen, Jonatan (AUTHOR), Hjorthøj, Carsten (AUTHOR), Reginsson, Gunnar W. (AUTHOR), Tyrfingsson, Thorarinn (AUTHOR), Runarsdottir, Valgerdur (AUTHOR), Qvist, Per (AUTHOR), Christensen, Jane Hvarregaard (AUTHOR), Bybjerg-Grauholm, Jonas (AUTHOR), Bækvad-Hansen, Marie (AUTHOR), Huckins, Laura M. (AUTHOR), Stahl, Eli A. (AUTHOR), Timmermann, Allan (AUTHOR), Agerbo, Esben (AUTHOR) |
| Source: |
Nature Neuroscience. Jul2019, Vol. 22 Issue 7, p1066-1074. 9p. 2 Charts, 4 Graphs. |
| Abstract: |
Cannabis is the most frequently used illicit psychoactive substance worldwide; around one in ten users become dependent. The risk for cannabis use disorder (CUD) has a strong genetic component, with twin heritability estimates ranging from 51 to 70%. Here we performed a genome-wide association study of CUD in 2,387 cases and 48,985 controls, followed by replication in 5,501 cases and 301,041 controls. We report a genome-wide significant risk locus for CUD (P = 9.31 × 10−12) that replicates in an independent population (Preplication = 3.27 × 10−3, Pmeta-analysis = 9.09 × 10−12). The index variant (rs56372821) is a strong expression quantitative trait locus for cholinergic receptor nicotinic α2 subunit (CHRNA2); analyses of the genetically regulated gene expression identified a significant association of CHRNA2 expression with CUD in brain tissue. At the polygenic level, analyses revealed a significant decrease in the risk of CUD with increased load of variants associated with cognitive performance. The results provide biological insights and inform on the genetic architecture of CUD. The study reports a genome-wide significant locus for cannabis use disorder, replicating in an independent cohort, and implicates CHRNA2, which encodes an acetylcholine receptor subunit, in the disorder by analyses of genetically regulated gene expression. [ABSTRACT FROM AUTHOR] |
|
Copyright of Nature Neuroscience is the property of Springer Nature and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) |
| Database: |
Psychology and Behavioral Sciences Collection |
